Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases | 5 | 2024 | 173 | 2.070 |
Why?
|
| Skin | 9 | 2022 | 582 | 1.800 |
Why?
|
| Hypopigmentation | 2 | 2022 | 5 | 1.620 |
Why?
|
| Dermatology | 4 | 2021 | 40 | 1.420 |
Why?
|
| Child | 20 | 2024 | 7174 | 1.150 |
Why?
|
| Acne Vulgaris | 2 | 2017 | 35 | 1.100 |
Why?
|
| Vitiligo | 2 | 2022 | 17 | 0.990 |
Why?
|
| Exanthema | 2 | 2023 | 39 | 0.980 |
Why?
|
| Skin Diseases, Vesiculobullous | 4 | 2015 | 18 | 0.970 |
Why?
|
| Hair | 2 | 2018 | 56 | 0.960 |
Why?
|
| Malassezia | 1 | 2024 | 2 | 0.950 |
Why?
|
| Dermatomycoses | 1 | 2024 | 9 | 0.950 |
Why?
|
| Infant | 12 | 2024 | 3160 | 0.920 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2023 | 5 | 0.890 |
Why?
|
| Food Addiction | 1 | 2023 | 1 | 0.890 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 15 | 0.870 |
Why?
|
| Dermatitis | 1 | 2023 | 34 | 0.870 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2023 | 12 | 0.860 |
Why?
|
| Autoimmune Diseases | 2 | 2023 | 249 | 0.830 |
Why?
|
| Granuloma Annulare | 1 | 2022 | 2 | 0.820 |
Why?
|
| Humans | 52 | 2024 | 89357 | 0.820 |
Why?
|
| Spider Bites | 1 | 2021 | 2 | 0.800 |
Why?
|
| Vaccines | 2 | 2014 | 83 | 0.800 |
Why?
|
| Internship and Residency | 2 | 2021 | 1045 | 0.790 |
Why?
|
| Papilloma | 1 | 2021 | 22 | 0.790 |
Why?
|
| Lichen Nitidus | 1 | 2021 | 1 | 0.780 |
Why?
|
| Herpes Zoster | 1 | 2022 | 79 | 0.780 |
Why?
|
| Fingers | 1 | 2021 | 69 | 0.760 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 211 | 0.750 |
Why?
|
| Infant, Newborn | 9 | 2024 | 2486 | 0.740 |
Why?
|
| Panniculitis | 2 | 2011 | 10 | 0.740 |
Why?
|
| Abnormalities, Multiple | 6 | 2022 | 234 | 0.730 |
Why?
|
| Skin Pigmentation | 2 | 2019 | 32 | 0.700 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 360 | 0.700 |
Why?
|
| Siblings | 2 | 2019 | 111 | 0.680 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2019 | 4 | 0.680 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2019 | 4 | 0.680 |
Why?
|
| Calcineurin Inhibitors | 2 | 2018 | 53 | 0.670 |
Why?
|
| Child, Preschool | 11 | 2024 | 3731 | 0.660 |
Why?
|
| Dermatitis, Atopic | 3 | 2016 | 55 | 0.640 |
Why?
|
| Alopecia Areata | 1 | 2018 | 4 | 0.620 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 10 | 0.620 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2018 | 24 | 0.600 |
Why?
|
| Molluscum Contagiosum | 1 | 2017 | 1 | 0.590 |
Why?
|
| Hypersensitivity | 1 | 2019 | 158 | 0.590 |
Why?
|
| Pediatrics | 1 | 2021 | 353 | 0.570 |
Why?
|
| Vascular Malformations | 2 | 2016 | 19 | 0.550 |
Why?
|
| Skin Diseases, Vascular | 1 | 2016 | 3 | 0.550 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 580 | 0.540 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 36 | 0.540 |
Why?
|
| Pandemics | 2 | 2022 | 773 | 0.540 |
Why?
|
| Ice | 1 | 2015 | 11 | 0.530 |
Why?
|
| Frostbite | 1 | 2015 | 8 | 0.520 |
Why?
|
| Cryotherapy | 1 | 2015 | 30 | 0.520 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 2 | 0.520 |
Why?
|
| Knee Injuries | 1 | 2015 | 54 | 0.510 |
Why?
|
| Arthroscopy | 1 | 2015 | 93 | 0.490 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 645 | 0.490 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 742 | 0.490 |
Why?
|
| Drug Eruptions | 1 | 2014 | 34 | 0.480 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 266 | 0.480 |
Why?
|
| Adolescent | 11 | 2024 | 9263 | 0.480 |
Why?
|
| Male | 23 | 2024 | 42411 | 0.460 |
Why?
|
| Limb Deformities, Congenital | 2 | 2016 | 20 | 0.460 |
Why?
|
| Mutation | 5 | 2019 | 4143 | 0.450 |
Why?
|
| Female | 23 | 2024 | 46202 | 0.450 |
Why?
|
| Leg Dermatoses | 1 | 2013 | 7 | 0.430 |
Why?
|
| Acrodermatitis | 1 | 2013 | 4 | 0.430 |
Why?
|
| Facial Dermatoses | 1 | 2013 | 13 | 0.430 |
Why?
|
| HIV Infections | 1 | 2022 | 840 | 0.430 |
Why?
|
| Netherton Syndrome | 1 | 2012 | 2 | 0.420 |
Why?
|
| Ultraviolet Therapy | 1 | 2012 | 16 | 0.410 |
Why?
|
| Aluminum Compounds | 1 | 2011 | 6 | 0.390 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2011 | 7 | 0.390 |
Why?
|
| Diagnosis, Differential | 6 | 2018 | 1597 | 0.390 |
Why?
|
| Retrospective Studies | 8 | 2023 | 9057 | 0.380 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2011 | 16 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 788 | 0.380 |
Why?
|
| Chlorides | 1 | 2011 | 103 | 0.380 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2010 | 5 | 0.360 |
Why?
|
| Beauty Culture | 1 | 2010 | 1 | 0.360 |
Why?
|
| Facial Neoplasms | 2 | 2007 | 25 | 0.360 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 82 | 0.360 |
Why?
|
| Alopecia | 1 | 2010 | 34 | 0.350 |
Why?
|
| Hemangioma | 2 | 2007 | 64 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1047 | 0.320 |
Why?
|
| Microphthalmos | 1 | 2008 | 7 | 0.320 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 11 | 0.320 |
Why?
|
| Pachyonychia Congenita | 1 | 2007 | 1 | 0.290 |
Why?
|
| Keratin-6 | 1 | 2007 | 3 | 0.290 |
Why?
|
| Lipoma | 1 | 2006 | 27 | 0.260 |
Why?
|
| Calcinosis | 1 | 2007 | 230 | 0.250 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2004 | 2 | 0.240 |
Why?
|
| Tooth Abnormalities | 1 | 2004 | 6 | 0.240 |
Why?
|
| Facial Asymmetry | 1 | 2004 | 12 | 0.240 |
Why?
|
| Tinea Versicolor | 1 | 2024 | 1 | 0.240 |
Why?
|
| Dermatitis, Seborrheic | 1 | 2024 | 3 | 0.240 |
Why?
|
| Inflammation | 1 | 2010 | 972 | 0.240 |
Why?
|
| Miliaria | 1 | 2004 | 1 | 0.230 |
Why?
|
| Social Stigma | 1 | 2024 | 63 | 0.230 |
Why?
|
| Clindamycin | 1 | 2023 | 15 | 0.220 |
Why?
|
| Syndrome | 4 | 2008 | 449 | 0.210 |
Why?
|
| Mental Health | 1 | 2024 | 178 | 0.210 |
Why?
|
| Darier Disease | 1 | 2022 | 4 | 0.200 |
Why?
|
| Hyperpigmentation | 1 | 2022 | 5 | 0.200 |
Why?
|
| Hair Diseases | 1 | 2022 | 9 | 0.200 |
Why?
|
| Oligopeptides | 1 | 2023 | 188 | 0.200 |
Why?
|
| Postpartum Period | 1 | 2023 | 144 | 0.200 |
Why?
|
| Smallpox Vaccine | 2 | 2014 | 13 | 0.200 |
Why?
|
| Herpesvirus 3, Human | 1 | 2022 | 41 | 0.200 |
Why?
|
| Public Assistance | 1 | 2021 | 6 | 0.200 |
Why?
|
| Spiders | 1 | 2021 | 16 | 0.200 |
Why?
|
| Erythema | 1 | 2021 | 29 | 0.200 |
Why?
|
| Scleroderma, Localized | 1 | 2021 | 9 | 0.190 |
Why?
|
| Necrosis | 1 | 2021 | 209 | 0.190 |
Why?
|
| Headache Disorders | 1 | 2021 | 6 | 0.190 |
Why?
|
| Hot Temperature | 1 | 2021 | 208 | 0.180 |
Why?
|
| Musculoskeletal Diseases | 1 | 2021 | 34 | 0.180 |
Why?
|
| Face | 1 | 2021 | 116 | 0.180 |
Why?
|
| Feeding Behavior | 1 | 2023 | 327 | 0.180 |
Why?
|
| Diet | 1 | 2023 | 442 | 0.170 |
Why?
|
| Hair Color | 1 | 2019 | 8 | 0.170 |
Why?
|
| Career Choice | 1 | 2021 | 148 | 0.170 |
Why?
|
| Melanins | 1 | 2019 | 23 | 0.170 |
Why?
|
| Melanocytes | 1 | 2019 | 57 | 0.170 |
Why?
|
| Culture | 1 | 2019 | 53 | 0.170 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 521 | 0.160 |
Why?
|
| Seizures | 1 | 2021 | 306 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 53 | 0.150 |
Why?
|
| Comorbidity | 1 | 2022 | 949 | 0.150 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2018 | 7 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1862 | 0.140 |
Why?
|
| Ectodermal Dysplasia | 1 | 2016 | 2 | 0.140 |
Why?
|
| Anodontia | 1 | 2016 | 2 | 0.140 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2016 | 3 | 0.140 |
Why?
|
| Nails, Malformed | 1 | 2016 | 3 | 0.140 |
Why?
|
| Curriculum | 1 | 2021 | 568 | 0.140 |
Why?
|
| Gestational Age | 1 | 2018 | 329 | 0.140 |
Why?
|
| Pigmentation Disorders | 1 | 2016 | 13 | 0.140 |
Why?
|
| Dermoscopy | 1 | 2016 | 6 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 111 | 0.130 |
Why?
|
| Pruritus | 1 | 2015 | 29 | 0.130 |
Why?
|
| Siphonaptera | 1 | 2015 | 8 | 0.130 |
Why?
|
| Pregnancy | 1 | 2023 | 3018 | 0.130 |
Why?
|
| Quality of Life | 1 | 2024 | 1668 | 0.130 |
Why?
|
| Infant, Premature | 1 | 2018 | 298 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2018 | 358 | 0.130 |
Why?
|
| Leukemoid Reaction | 1 | 2015 | 5 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 233 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1365 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2021 | 2303 | 0.120 |
Why?
|
| Down Syndrome | 1 | 2015 | 55 | 0.120 |
Why?
|
| Ichthyosis Vulgaris | 1 | 2014 | 1 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 533 | 0.120 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 35 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 420 | 0.120 |
Why?
|
| Disease Management | 1 | 2017 | 329 | 0.120 |
Why?
|
| Breast | 1 | 2016 | 292 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2015 | 231 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 290 | 0.120 |
Why?
|
| Pedigree | 1 | 2016 | 970 | 0.120 |
Why?
|
| Buttocks | 1 | 2013 | 10 | 0.110 |
Why?
|
| Arm | 1 | 2013 | 97 | 0.100 |
Why?
|
| Patch Tests | 1 | 2011 | 4 | 0.100 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2011 | 3 | 0.100 |
Why?
|
| Hepatitis B Vaccines | 1 | 2011 | 16 | 0.100 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 28 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1799 | 0.100 |
Why?
|
| United States | 3 | 2024 | 6989 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2012 | 268 | 0.090 |
Why?
|
| Granulation Tissue | 1 | 2010 | 15 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 2340 | 0.090 |
Why?
|
| Debridement | 1 | 2010 | 57 | 0.090 |
Why?
|
| Microscopy | 1 | 2010 | 87 | 0.090 |
Why?
|
| Animals | 5 | 2021 | 27371 | 0.090 |
Why?
|
| Scalp | 1 | 2010 | 72 | 0.090 |
Why?
|
| Maus Elberfeld virus | 4 | 1990 | 34 | 0.090 |
Why?
|
| Enterovirus | 4 | 1990 | 34 | 0.090 |
Why?
|
| Kaposi Varicelliform Eruption | 1 | 2008 | 6 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3666 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 55 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2016 | 1653 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2010 | 259 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 1840 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1714 | 0.070 |
Why?
|
| Biopsy | 1 | 2011 | 1184 | 0.070 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2006 | 20 | 0.070 |
Why?
|
| Ear, External | 1 | 2007 | 26 | 0.070 |
Why?
|
| Sternum | 1 | 2006 | 34 | 0.070 |
Why?
|
| Heel | 1 | 2006 | 4 | 0.070 |
Why?
|
| Groin | 1 | 2006 | 9 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2024 | 950 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8241 | 0.060 |
Why?
|
| Skull | 1 | 2006 | 255 | 0.060 |
Why?
|
| Adult | 2 | 2022 | 26607 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 809 | 0.060 |
Why?
|
| Stereotyping | 1 | 2024 | 15 | 0.060 |
Why?
|
| Canada | 1 | 2024 | 208 | 0.060 |
Why?
|
| Phenotype | 1 | 2010 | 2440 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2006 | 363 | 0.060 |
Why?
|
| Fever | 1 | 2004 | 128 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 192 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 25974 | 0.050 |
Why?
|
| Eyebrows | 1 | 2022 | 10 | 0.050 |
Why?
|
| Retinoids | 1 | 2022 | 18 | 0.050 |
Why?
|
| Anxiety | 1 | 2024 | 308 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 144 | 0.050 |
Why?
|
| Critical Illness | 1 | 2004 | 306 | 0.050 |
Why?
|
| Photography | 1 | 2021 | 37 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 312 | 0.040 |
Why?
|
| Depression | 1 | 2024 | 505 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2012 | 65 | 0.040 |
Why?
|
| Vitamin D | 1 | 2022 | 269 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2008 | 262 | 0.040 |
Why?
|
| Genitalia | 1 | 2018 | 21 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2018 | 96 | 0.040 |
Why?
|
| Anal Canal | 1 | 2018 | 88 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2021 | 751 | 0.030 |
Why?
|
| Mothers | 1 | 2016 | 142 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1990 | 646 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 922 | 0.030 |
Why?
|
| Genes, Viral | 2 | 1990 | 117 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 273 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 323 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 73 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 374 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1990 | 301 | 0.020 |
Why?
|
| Capsid | 1 | 1989 | 34 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 162 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3448 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 14 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3783 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 51 | 0.020 |
Why?
|
| Organophosphonates | 1 | 2008 | 50 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 163 | 0.020 |
Why?
|
| Family Health | 1 | 2008 | 162 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2007 | 41 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 171 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 128 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 237 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2008 | 184 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 975 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2008 | 309 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 465 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 202 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 1595 | 0.010 |
Why?
|
| Neurons | 1 | 1990 | 1584 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 1990 | 3027 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 2285 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1990 | 2062 | 0.010 |
Why?
|
| Base Sequence | 2 | 1989 | 2327 | 0.010 |
Why?
|
| DNA | 2 | 1990 | 1308 | 0.010 |
Why?
|
| Mice | 3 | 1990 | 11761 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1990 | 19 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1990 | 149 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 1989 | 32 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1989 | 156 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1990 | 115 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1989 | 80 | 0.010 |
Why?
|
| Enterovirus Infections | 1 | 1989 | 41 | 0.010 |
Why?
|
| Plasmids | 1 | 1989 | 291 | 0.010 |
Why?
|
| Epitopes | 1 | 1989 | 255 | 0.010 |
Why?
|
| Virulence | 1 | 1989 | 280 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1990 | 529 | 0.000 |
Why?
|
| Picornaviridae | 1 | 1988 | 8 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1989 | 255 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1989 | 446 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1990 | 445 | 0.000 |
Why?
|
| Transfection | 1 | 1989 | 911 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1988 | 317 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 389 | 0.000 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 382 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1989 | 1157 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 1412 | 0.000 |
Why?
|